Pharm
Fosphenytoin
search
Fosphenytoin
, Cerebyx
See Also
Seizure Disorder
Indications
Status Epilepticus
Seizure Disorder
and unable to take oral medications
Contraindications
Pregnancy
Cardiac conduction delays
Mechanism
Hydantoin
anticonvulsant
Water-soluble phosphate ester prodrug of
Phenytoin
Fosphenytoin is hydrolyzed to
Phenytoin
by phosphatases
Increases
Neuron
al
Sodium
efflux and stabilizes
Neuron
al membranes in the motor cortex
Suppresses the propagation of
Seizure
activity in the motor cortex
Dosing
Dosed in
Phenytoin
equivalents (PE)
Transition to oral
Phenytoin
as soon as possible
Therapeutic serum level range: 10 to 20 mcg/ml
Status Epilepticus
Dose: 15 to 20 PE mg/kg IV or IM (at 3 mg/kg/min up to 100 to 150 mg/min) up to 1000 mg maximum
Avoid IM dosing if possible
Non-Emergent Loading Infusion
Dose: 10 to 15 PE mg/kg IV (at 2 mg/kg/min up to 100 to 150 mg/min) up to 1000 mg maximum
Maintenance
Follows loading dose by 12 hours (
Status Epilepticus
or non-emergent loading)
For initial dosing only (later dosing should be based on serum levels)
Start: 2 to 4 PE mg/kg infused slowly (1-2 mg/kg/min up to 100 mg/min) every 12 hours
Subsequent dosing (based on serum levels)
Dose 4 to 8 mg PE/kg/day divided every 12 hours based on serum levels
Preferred over
Phenytoin
for
Status Epilepticus
Fosphenytoin can be infused with dextrose
Fosphenytoin has lower risk of
Arrhythmia
(due to no
Ethylene Glycol
in base)
Fosphenytoin may be given IM or delivered a faster IV rate (not tissue toxic)
However onset of activity is similar to that with
Phenytoin
(as Fosphenytoin is converted to active
Phenytoin
form)
Safety
Pregnancy Category X (Known
Teratogen
)
See
Fetal Hydantoin Syndrome
Unknown Safety in
Lactation
Adverse Effects
See
Phenytoin
Severe
Hypotension
and
Cardiac Dysrhythmia
s
Infuse slowly
Cardiac and hemodynamic monitoring during infusion
Drug Interactions
See
Phenytoin
Resources
Fosphenytoin (DailyMed)
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2
References
(2022) Presc Lett, Resource #361206, Antiseizure Medications
Olson (2020) Clinical
Pharmacology
, Medmaster Miami, p. 56-7
Hamilton (2020) Tarascon Pocket Pharmacopoeia
Type your search phrase here